ANAVEX LIFE SCIENCES CORP. Earnings Per Share, Basic and Diluted
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Earnings Per Share, Basic and Diluted of -$0.14 per share for the 3-month period ending 2021-12-31, per its 10-Q filed 2022-02-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-02-09
- ANAVEX LIFE SCIENCES CORP. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.14.
- ANAVEX LIFE SCIENCES CORP. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.14.
- ANAVEX LIFE SCIENCES CORP. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.12.
- ANAVEX LIFE SCIENCES CORP. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.12.
- ANAVEX LIFE SCIENCES CORP. earnings per share, basic and diluted for fiscal 2021 was -$0.54.
- ANAVEX LIFE SCIENCES CORP. earnings per share, basic and diluted for fiscal 2020 was -$0.45.
- ANAVEX LIFE SCIENCES CORP. earnings per share, basic and diluted for fiscal 2019 was -$0.54.
- ANAVEX LIFE SCIENCES CORP. earnings per share, basic and diluted for fiscal 2018 was -$0.39.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$0.14 10-Q · filed 2022-02-09 | ||||||
| 2021-09-30 | -$0.54 10-K · filed 2021-11-24 | ||||||
| 2021-06-30 | -$0.14 10-Q · filed 2021-08-12 | -$0.39 10-Q · filed 2021-08-12 | |||||
| 2021-03-31 | -$0.12 10-Q · filed 2021-05-13 | -$0.24 10-Q · filed 2021-05-13 | |||||
| 2020-12-31 | -$0.12 10-Q · filed 2022-02-09 | ||||||
| 2020-09-30 | -$0.45 10-K · filed 2021-11-24 | ||||||
| 2020-06-30 | -$0.11 10-Q · filed 2021-08-12 | -$0.35 10-Q · filed 2021-08-12 | |||||
| 2020-03-31 | -$0.12 10-Q · filed 2021-05-13 | -$0.24 10-Q · filed 2021-05-13 | |||||
| 2019-12-31 | -$0.12 10-Q · filed 2021-02-16 | ||||||
| 2019-09-30 | -$0.54 10-K · filed 2020-12-28 | ||||||
| 2019-06-30 | -$0.13 10-Q · filed 2020-08-06 | -$0.14 10-Q · filed 2019-08-07 | -$0.43 10-Q · filed 2020-08-06 | -$0.47 10-Q · filed 2019-08-07 | |||
| 2019-03-31 | -$0.15 10-Q · filed 2020-05-07 | -$0.17 10-Q · filed 2019-05-09 | -$0.30 10-Q · filed 2020-05-07 | -$0.33 10-Q · filed 2019-05-09 | |||
| 2018-12-31 | -$0.15 10-Q · filed 2020-02-06 | -$0.16 10-Q · filed 2019-02-07 | |||||
| 2018-09-30 | -$0.39 10-K · filed 2019-12-16 | ||||||
| 2018-06-30 | -$0.06 10-Q · filed 2019-08-07 | -$0.26 10-Q · filed 2019-08-07 | |||||
| 2018-03-31 | -$0.11 10-Q · filed 2019-05-09 | -$0.20 10-Q · filed 2019-05-09 | |||||
| 2017-12-31 | -$0.09 10-Q · filed 2019-02-07 | ||||||
| 2017-09-30 | -$0.33 10-K · filed 2019-01-25 | ||||||
| 2017-06-30 | -$0.04 10-Q · filed 2018-08-09 | -$0.09 10-Q · filed 2017-08-07 | -$0.12 10-Q · filed 2018-08-09 | -$0.21 10-Q · filed 2017-08-07 | |||
| 2017-03-31 | -$0.04 10-Q · filed 2018-05-10 | -$0.12 10-Q · filed 2018-05-10 | |||||
| 2016-12-31 | -$0.08 10-Q · filed 2018-02-07 | ||||||
| 2016-09-30 | -$0.42 10-K · filed 2019-01-25 | ||||||
| 2016-06-30 | -$0.06 10-Q · filed 2017-08-07 | -$0.24 10-Q · filed 2017-08-07 | |||||
| 2015-09-30 | -$0.65 10-K · filed 2017-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |